Pharming Group NV (PHAR)
12.50
-0.12
(-0.95%)
USD |
NASDAQ |
May 19, 15:04
Pharming Group Shareholders Equity (Quarterly) : 268.96M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| uniQure NV | 149.34M |
| ProQR Therapeutics NV | 43.32M |
| argenx SE | -- |
| NewAmsterdam Pharma Co. NV | 665.22M |
| CervoMed, Inc. | 10.62M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 489.36M |
| Total Liabilities (Quarterly) | 220.41M |
| Debt to Equity Ratio | 0.4321 |
| Current Ratio | 2.630 |
| Net Debt Paydown Yield | -0.07% |